Risk of CRO Business Stagnation Due to Postponement or Loss of Contracted Clinical Trial Projects
In the CRO business, there is a risk that the progress and acquisition of contracted projects will stagnate and earnings will temporarily deteriorate due to the postponement of planned clinical trials and the loss of large contract projects.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.